Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berenbaum

Showing results (671-680 of 805) with videos related to

Pageof 81
Sort By:
Osteoarthritis and Cartilage Open|June 3, 2024
Severity and progression of structural hand OA is not associated with progression of structural knee OA: The IMI-APPROACH cohortSietse E S Terpstra, Lotte A van de Stadt, Francis Berenbaum, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitorsRomain-David Seban, Laura Mezquita, Arnaud Berenbaum, et al.
Arthritis Research & Therapy|January 13, 2019
Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritisSabine Trellu, Alice Courties, Stéphane Jaisson, et al.
Osteoarthritis and Cartilage|October 14, 2025
Do rates of femorotibial cartilage loss in Kellgren-Lawrence 2 and 3 knees differ between those with mild-moderate vs. severe patellofemoral structural damage? - Data from the FNIH and IMI-APPROACH cohortsFrank W Roemer, Mylène Jansen, Susanne Maschek, et al.
Arthritis Care & Research|February 13, 2013
Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohortAlain Saraux, Gabriel J Tobón, Mathilde Benhamou, et al.
Osteoarthritis and Cartilage Open|January 14, 2026
How are patient-reported pain outcomes associated with biomarker and structural pathology subtypes in knee osteoarthritis? An explorative evaluation in the IMI-APPROACH cohortM P Jansen, S C Mastbergen, W Wirth, et al.
Plos One|March 23, 2022
GaitSmart motion analysis compared to commonly used function outcome measures in the IMI-APPROACH knee osteoarthritis cohortEefje M van Helvoort, D Hodgins, Simon C Mastbergen, et al.
Plos One|June 24, 2025
Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohortMieke L M Bentvelzen, Paco M J Welsing, Philippe Moingeon, et al.
RMD Open|August 16, 2019
Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendationsJoanna Kedra, Timothy Radstake, Aridaman Pandit, et al.
The Journal of Rheumatology|August 17, 2012
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of RheumatologyDaniel Wendling, Maxime Dougados, Francis Berenbaum, et al.
Pageof 81

Showing results (671-680 of 805) with videos related to

Sort By:
Pageof 81
Osteoarthritis and Cartilage Open|June 3, 2024
Severity and progression of structural hand OA is not associated with progression of structural knee OA: The IMI-APPROACH cohortSietse E S Terpstra, Lotte A van de Stadt, Francis Berenbaum, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitorsRomain-David Seban, Laura Mezquita, Arnaud Berenbaum, et al.
Arthritis Research & Therapy|January 13, 2019
Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritisSabine Trellu, Alice Courties, Stéphane Jaisson, et al.
Osteoarthritis and Cartilage|October 14, 2025
Do rates of femorotibial cartilage loss in Kellgren-Lawrence 2 and 3 knees differ between those with mild-moderate vs. severe patellofemoral structural damage? - Data from the FNIH and IMI-APPROACH cohortsFrank W Roemer, Mylène Jansen, Susanne Maschek, et al.
Arthritis Care & Research|February 13, 2013
Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohortAlain Saraux, Gabriel J Tobón, Mathilde Benhamou, et al.
Osteoarthritis and Cartilage Open|January 14, 2026
How are patient-reported pain outcomes associated with biomarker and structural pathology subtypes in knee osteoarthritis? An explorative evaluation in the IMI-APPROACH cohortM P Jansen, S C Mastbergen, W Wirth, et al.
Plos One|March 23, 2022
GaitSmart motion analysis compared to commonly used function outcome measures in the IMI-APPROACH knee osteoarthritis cohortEefje M van Helvoort, D Hodgins, Simon C Mastbergen, et al.
Plos One|June 24, 2025
Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohortMieke L M Bentvelzen, Paco M J Welsing, Philippe Moingeon, et al.
RMD Open|August 16, 2019
Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendationsJoanna Kedra, Timothy Radstake, Aridaman Pandit, et al.
The Journal of Rheumatology|August 17, 2012
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of RheumatologyDaniel Wendling, Maxime Dougados, Francis Berenbaum, et al.
Pageof 81